Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support
Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|9|3|279-288
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.9, Iss.3, 2003-01, pp. : 279-288
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
